Open AccessLiposome Encapsulated Doxorubicin Citrate (Ledc) as an Alternative Therapeutic Option for Patients with Recurrent Ovarian Cancer Suffering from Doxorubicin-Related Cutaneous Toxicity
Author(s) -
Roberto Angioli
Publication year - 2013
Publication title -
chemotherapy
Language(s) - English
Resource type - Journals
ISSN - 2167-7700
DOI - 10.4172/2167-7700.1000113
Subject(s) - doxorubicin , ovarian cancer , toxicity , medicine , chemotherapy , pharmacology , cancer , oncology